Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk

References

• National Institute of Mental Health. The Numbers Count: Mental Disorders in America. NIH MD, USA (2008).
   Google Scholar
• Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch. Gen. Psychiatry62, 617–627 (2005).
   PubMed Web of Science ®Google Scholar
• US Census Bureau Population Estimates by Demographic Characteristics. Table 2: annual estimates of the population by selected age groups and sex for the United States: April 1, 2000 to July 1, 2004 (NC-EST2004–02). US Census Bureau, Washington, DC, USA (2005).
   Google Scholar
• World Health Organization. The World Health Report 2004: Changing History, Annex Table 3: Burden of Disease in DALYs by Cause, Sex, and Mortality Stratum in WHO Regions, Estimates for 2002. WHO, Geneva, Switzerland (2004).
   Google Scholar
• Kessler RC, Akiskal HS, Ames M et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am. J. Psychiatry163, 1561–1568 (2006).
   PubMed Web of Science ®Google Scholar
• Moller HJ, Demyttenaere K, Sacchetti E, Rush AJ, Montgomery SA. Improving the chance of recovery from the short- and long-term consequences of depression. Int. Clin. Psychopharmacol.18(4), 219–225 (2003).
   PubMed Web of Science ®Google Scholar
• Akerblad AC, Bengtsson F, von Knorring L, Ekselius L. Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study. Int. Clin. Psychopharmacol.21(2), 117–124 (2006).
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Enzlin P, Dewe W et al. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. J. Clin. Psychiatry62(Suppl. 22), 34–37 (2001).
   PubMed Web of Science ®Google Scholar
• Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ319(7210), 612–615 (1999).
   PubMed Web of Science ®Google Scholar
• Melfi CA, Chawla AJ, Croghan TW et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch. Gen. Psychiatry55(12), 1128–1132 (1998).
   PubMed Web of Science ®Google Scholar
• Thase ME, Nierenberg AA, B. Keller MB, Panagides J; Relapse Prevention Study Group. Efficacy of mirtazapine for prevention of depressive relapse: a placebo controlled double-blind trial of recently remitted high-risk patients. J. Clin. Psychiatry62, 782–788 (2001).
   PubMed Web of Science ®Google Scholar
• Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr. Scand.105(3), 164–172 (2002).
   PubMed Web of Science ®Google Scholar
• Tacchi MJ, Scott J. Improving Adherence in Schizophrenia and Bipolar Disorders. Wiley, Chichester, UK (2005).
   Google Scholar
• Tatarelli R. Drugs and human interactions. Ann. Ist. Super. Sanita28(2), 197–202 (1992).
   PubMedGoogle Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action. WHO, Geneva, Switzerland (2003).
   Google Scholar
• Noble LM. Doctor–patient communication and adherence to treatment. In: Adherence to Treatment in Medical Conditions. Myer LB, Midence K (Eds). Wiley, London, UK 51–82 (1998).
   Google Scholar
• Depression Guideline Panel. Depression in Primary Care, Volume 2: Treatment of Major Depression, Clinical Practice Guideline, Number 5. US Department of Health and Human Services, Public Health Service, MD, USA (1993).
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am. J. Psychiatry157(4 Suppl.), 1–45 (2000).
   Google Scholar
• National Collaborating Centre for Mental Health. Depression. Management of Depression in Primary and Secondary Care. National Institute for Clinical Excellence, London, UK (2004).
   Google Scholar
• Isometsa E, Lindfors O, Pirkola S et al. The National Finnish current care guidelines for the treatment of depression. An overview. Psychiatr. Fennica34, 181–196 (2003).
   Google Scholar
• Ahrens B, Linden M. Faktoren der Chronifizierung von Depressionen. Munch. Med. Wochenschr.133, 49–50 (1991).
   Google Scholar
• Fritze J. Wie lange sollten Antidepressiva verordnet warden? Psychopharmakotherapie5, 7–25 (1997).
   Google Scholar
• Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA289, 3145–3151 (2003).
   PubMed Web of Science ®Google Scholar
• Holma IAK, Holma KM, Melartin TK, Isometsa ET. Maintenance pharmacotherapy for recurrent major depressive disorder: 5-year follow-up study. Br. J. Psychiatry193, 163–164 (2008).
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr. Scand. Suppl.403, 50–56 (2000).
   PubMedGoogle Scholar
• Johnson DAW. Treatment of depression in general practice. BMJ2, 18 (1973).
   PubMedGoogle Scholar
• Thompson J, Rankin H, Ashcroft CW et al. The treatment of depression in general practice. Psychol. Med.12, 741 (1982).
   PubMed Web of Science ®Google Scholar
• Johnson DA. Depression: treatment compliance in general practice. Acta Psychiatr. Scand. Suppl.290, 447–453 (1981).
   PubMedGoogle Scholar
• Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br. J. Psychiatry170, 120–127 (1997).
   PubMed Web of Science ®Google Scholar
• Robinson P, Bush T, Von Korff M et al. Primary care physician use of cognitive behavioral techniques with depressed patients. J. Fam. Pract.40(4), 352–357 (1995).
   PubMed Web of Science ®Google Scholar
• Prein RF. Long-term treatment of affective disorders. In: Psychopharmacology. The Third Generation of Progress. Meltzer HY (Ed.). Raven Press, NY, USA 1051–1058 (1987).
   Google Scholar
• Maixner SM, Greden JF. Extended antidepressant maintenance and discontinuation syndromes. Depress. Anxiety8(Suppl. 1), 43–53 (1998).
   PubMedGoogle Scholar
• Lin EH, Von Korff M, Katon W et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med. Care33(1), 67–74 (1995).
   PubMed Web of Science ®Google Scholar
• Bultman DC, Svarstad BL. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J. Am. Pharm. Assoc.42, 36–43 (2002).
   Google Scholar
• Frank E, Perel JM, Mallinger AG, Thase ME, Kupfer DJ. Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol. Bull.28(3), 231–235 (1992).
   PubMedGoogle Scholar
• Sood N, Treglia M, Obenchain RL et al. Determinants of antidepressant treatment outcome. Am. J. Manag. Care6(12), 1327–1336 (2000).
   PubMed Web of Science ®Google Scholar
• Muller-Oerlinghausen B, Berghofer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can. J. Psychiatry48(7), 433–439 (2003).
   PubMed Web of Science ®Google Scholar
• Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs17(7), 491–511 (2003).
   PubMed Web of Science ®Google Scholar
• Craig TJ, Ye Q, Bromet EJ. Mortality among first-admission patients with psychosis. Compr. Psychiatry47(4), 246–251 (2006).
   PubMedGoogle Scholar
• Dutta R, Boydell J, Kennedy N et al. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol. Med.37(6), 839–847 (2007).
   PubMed Web of Science ®Google Scholar
• Khalsa HM, Salvatore P, Hennen J et al. Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J. Affect. Disord.106(1–2), 179–184 (2008).
   PubMed Web of Science ®Google Scholar
• Berk M, Berk L. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events. Ann. Clin. Psychiatry15(3–4), 217–224 (2003).
   PubMedGoogle Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch. Gen. Psychiatry48(12), 1082–1088 (1991).
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, McElroy SL. Outcome in the pharmacologic treatment of bipolar disorder. J. Clin. Psychopharmacol.16(2 Suppl 1), S15–S23 (1996).
   PubMed Web of Science ®Google Scholar
• Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am. J. Psychiatry159(11), 1927–1929 (2002).
   PubMed Web of Science ®Google Scholar
• Coletti DJ, Leigh E, Gallelli KA, Kafantaris V. Patterns of adherence to treatment in adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol.15(6), 913–917 (2005).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Faedda GL et al. Latency, discontinuation, and re-use of lithium treatment. In: Lithium in Neuropsychiatry: the Comprehensive Guide. Bauer M, Grof P, Muller-Oerlinghausen B (Eds). Taylor & Francis, London, UK 465–481 (2006).
   Google Scholar
• Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord.8(3), 232–241 (2006).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum. Psychopharmacol.23(2), 95–105 (2008).
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Altshuler L et al. Lithium-discontinuation induced refractoriness: preliminary observations. Am. J. Psychiatry149, 1727–1729 (1992).
   PubMed Web of Science ®Google Scholar
• Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatrica12, 128–130 (2000).
   PubMed Web of Science ®Google Scholar
• Bech P, Vendesborg P, Rafaelsen O. Lithium maintenance treatment of manic-melancholic patients: its role in the daily routine. Acta Psychiatr. Scand.53, 70–81 (1976).
   PubMed Web of Science ®Google Scholar
• Cochran SD. Compliance with lithium regimens in the out-patient treatment of bipolar affective disorders. J. Compliance Health Care1, 151–169 (1986).
   Google Scholar
• Johnson R, Mcfarland B. Lithium use and discontinuation in a health maintenance organisation. Am. J. Psychiatry153, 993–1000 (1998).
   Web of Science ®Google Scholar
• Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch. Gen. Psychiatry36(8 Spec. No.), 866–869 (1979).
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol. Bull.33(1), 87–91 (1997).
   PubMed Web of Science ®Google Scholar
• Aagaard J, Vestergaard P, Maarbjerg K. Adherence to lithium prophylaxis, 2: multivariate analysis of clinical and psychosocial predictors of non-adherence. Pharmacopsychiatry21, 166–170 (1988).
   PubMed Web of Science ®Google Scholar
• Danion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry20(5), 230–231 (1987).
   PubMed Web of Science ®Google Scholar
• Smith CM, Barzman D, Pristach CA. Effect of patient and family insight on compliance of schizophrenic patients. J. Clin. Pharmacol.37, 147–154 (1997).
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Keck PE Jr, McElroy SL et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch. Gen. Psychiatry55(1), 49–55 (1998).
   PubMed Web of Science ®Google Scholar
• Liraud F, Verdoux H. Caracteristiques cliniques et pronostiques associees a une comorbidite addictive chez des patients hospitalises en psychiatrie. Encephale26, 16–23 (2000).
   PubMedGoogle Scholar
• Verdoux H, Lengronne J, Liraud F et al. Predictors and impact on outcome of medication adherence. A two-year follow-up study of first-admitted subjects with psychosis. Acta Psychiatr. Scand.102, 203–210 (2000).
   PubMed Web of Science ®Google Scholar
• Manwani SG, Szilagyi KA, Zablotsky B et al. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J. Clin. Psychiatry68(8), 1172–1176 (2007).
   PubMed Web of Science ®Google Scholar
• Jamison KR. Medication compliance. In: Manic Depressive Illness. Goodwin FK, Jamison KR (Eds). Oxford University Press, London, UK 756–757 (1990).
   Google Scholar
• Fabre L, Abuzzahab F, Amin M et al. Sertraline safety and efficacy in major depression: a double-blind, fixed-dose comparison with placebo. Biol. Psychiatry38, 592–602 (1995).
   PubMed Web of Science ®Google Scholar
• Preskorn S, Lane R. Sertraline 50 mg daily: the optimal dose in the treatment of depression. Int. J. Psychopharmacol.10, 129–141 (1995).
   PubMed Web of Science ®Google Scholar
• Thompson C. Management of depression in real-life settings: knowledge gained from large-scale clinical trials. Int. Clin. sychopharmacol. (Suppl. 3), 21–25 (1994).
   Google Scholar
• Revicki DA, Brown RE, Keller MB et al. Cost–effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J. Clin. Psychiatry58(2), 47–58 (1997).
   PubMed Web of Science ®Google Scholar
• Madsen JW, McQuaid JR, Craighead WE. Working with reactant patients: are we prescribing nonadherence? Depress. Anxiety26, 129–134 (2009).
   PubMed Web of Science ®Google Scholar
• Perahia DG, Quail D, Gandhi P, Walker DJ, Peveler RC. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. J. Affect. Disord.108(1–2), 33–41 (2008).
   PubMed Web of Science ®Google Scholar
• Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin. Ther.25(8), 2289–2304 (2003).
   PubMed Web of Science ®Google Scholar
• Toni C, Pertugi G, Frare F, Mata B, Akiskal HS. Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants. Acta Psychiatr. Scand.110, 130–137 (2004).
   PubMed Web of Science ®Google Scholar
• Curtis GC, Massana J, Udina C, Ayuso JL, Perugi G. Maintenance of drug therapy of panic disorder. J. Psychiatr. Res.27(Suppl. 1), 127–142 (1993).
   PubMed Web of Science ®Google Scholar
• Toni C, Perugi G, Frare F et al. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry33, 1–11 (2000).
   PubMed Web of Science ®Google Scholar
• Bollini P, Tibaldi G, Testa C, Munizza C. Understanding treatment adherence in affective disorders: a qualitative study. J. Psychiatr. Ment. Health Nurs.11, 668–674 (2004).
   PubMedGoogle Scholar
• Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J. Clin. Psychiatry67(Suppl. 4), 14–21 (2006).
   PubMed Web of Science ®Google Scholar
• Nemeroff CB. New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum. Psychopharmacol.17(Suppl. 1), S13–S16 (2002).
   PubMed Web of Science ®Google Scholar
• Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol. Assess.8, 1–72 (2004).
   Web of Science ®Google Scholar
• Verkerk K, Van Veenendaal H, Severens JL, Hendriks EJ, Burgers JS. Considered judgment in evidence-based guideline development. Int. J. Qual. Health Care18, 365–369 (2006).
   PubMed Web of Science ®Google Scholar
• Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med. Care30(1), 67–76 (1992).
   PubMed Web of Science ®Google Scholar
• Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J. Clin. Psychiatry61(Suppl. 2), 6–9 (2000).
   PubMed Web of Science ®Google Scholar
• Aikens JE, Kroenke K, Swindle RW, Eckert GJ. Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen. Hosp. Psychiatry27, 229–236 (2005).
   PubMed Web of Science ®Google Scholar
• Schwenk TL, Evans DL, Laden SK, Lewis L. Treatment outcome and physician-patient communication in primary care patients with chronic, recurrent depression. Am. J. Psychiatry161(10), 1892–1901 (2004).
   PubMed Web of Science ®Google Scholar
• Givens JL, Datto CJ, Ruckdeschel K et al. Older patients’ aversion to antidepressants: a qualitative study. J. Gen. Intern. Med.21, 146–151 (2006).
   PubMed Web of Science ®Google Scholar
• Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition treatment. Cognit. Ther. Res.16, 143–163 (1992).
   Web of Science ®Google Scholar
• Brown C, Dunbar-Jacob J, Palenchar DR et al. Primary care patients’ personal illness models for depression: a preliminary investigation. Fam. Pract.18, 314–320 (2001).
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Katon WJ, Russo JE et al. Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression. J. Am. Board Fam. Pract.16, 22–31 (2003).
   PubMedGoogle Scholar
• Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients’ beliefs about the necessity and harmfulness of antidepressants. Ann. Fam. Med.6(1), 23–29 (2008).
   PubMed Web of Science ®Google Scholar
• Fawcett J. Compliance: definitions and key issues. J. Clin. Psychiatry56(Suppl. 1), 4–8 (1995).
   PubMed Web of Science ®Google Scholar
• Paykel ES. Psychotherapy, medication combinations, and compliance. J. Clin. Psychiatry56(Suppl. 1), 24–30 (1995).
   PubMed Web of Science ®Google Scholar
• Bultman D, Svarstad B. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ. Couns.40, 173–185 (2000).
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Siegel LR. Alliance not compliance: a philosophy of outpatient care. J. Clin. Psychiatry56(Suppl. 1), 11–16 (1995).
   PubMed Web of Science ®Google Scholar
• Woller KM, Buboltz WC Jr, Loveland JM. Psychological reactance: examination across age, ethnicity, and gender. Am. J. Psychol.120(1), 15–24 (2007).
   PubMed Web of Science ®Google Scholar
• Brehm JW. A Theory of Psychological Reactance. Academic Press, NY, USA (1966).
   Google Scholar
• Brehm JW, Brehm SS. Psychological Reactance. Wiley, NY, USA (1981).
   Google Scholar
• Fogarty JS. Reactance theory and patient nonadherence. Soc. Sci. Med.45, 1277–1288 (1997).
   PubMed Web of Science ®Google Scholar
• Seibel CA, Dowd ET. Reactance and therapeutic noncompliance. Cognit. Ther. Res.23, 373–379 (1999).
   Web of Science ®Google Scholar
• Beutler LE, Engle D, Mohr D et al. Predictors of differential response to cognitive, experiential, and self-directed psychotherapeutic procedures. J. Consult. Clin. Psychol.59(2), 333–340 (1991).
   PubMed Web of Science ®Google Scholar
• Karno MP, Longabaugh R. Less directiveness by therapists improves drinking outcomes of reactant clients in alcoholism treatment. J. Consult. Clin. Psychol.73(2), 262–267 (2005).
   PubMed Web of Science ®Google Scholar
• Karno MP, Longabaugh R. An examination of how therapist directiveness interacts with patient anger and reactance to predict alcohol use. J. Stud. Alcohol66(6), 825–832 (2005).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Bipolar Disorder. American Psychiatric Association, Washington, DC, USA (2002).
   Google Scholar
• Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. Br. J. Psychiatry164, 741–746 (1994).
   PubMed Web of Science ®Google Scholar
• Jamison KR, Akiskal HS. Medication compliance in patients with bipolar disorder. Psychiatr. Clin. North Am.6(1), 175–192 (1983).
   PubMed Web of Science ®Google Scholar
• Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient’s reasons for nonadherence. Pharmacopsychiatry21(3), 121–125 (1988).
   PubMed Web of Science ®Google Scholar
• Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J. Clin. Psychiatry50(4), 127–131 (1989).
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, McElroy SL, Strakowski SM et al. Factors associated with pharmacologic noncompliance in patients with mania. J. Clin. Psychiatry57(7), 292–297 (1996).
   PubMed Web of Science ®Google Scholar
• Weiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J. Clin. Psychiatry59(4), 172–174 (1998).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ. Enhancing treatment with psychotropic medicines. Bull. Menninger Clin.58(2), 224–241 (1994).
   PubMed Web of Science ®Google Scholar
• DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM. Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am. J. Psychiatry164(4), 582–590 (2007).
   PubMed Web of Science ®Google Scholar
• Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J. Clin. Psychiatry63(5), 384–390 (2002).
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ. Longitudinal outcome and medication non-compliance among manic patients with and without mood- incongruent psychotic features. J. Nerv. Ment. Dis.180, 703–711 (1992).
   PubMed Web of Science ®Google Scholar
• Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex and carbamazepine. J. Affect. Disord.103(1–3), 5–11 (2007).
   PubMed Web of Science ®Google Scholar
• Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J. Affect. Disord.59(3), 237–241 (2000).
   PubMed Web of Science ®Google Scholar
• Trauer T, Sacks T. The relationship between insight and medication adherence in severely mentally ill clients treated in the community. Acta Psychiatr. Scand.102, 211–216 (2000).
   PubMed Web of Science ®Google Scholar
• Kleindienst N, Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? J. Clin. Psychiatry65(7), 966–974 (2004).
   PubMed Web of Science ®Google Scholar
• Yen CF, Chen CS, Ko CH et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry Clin. Neurosci.59, 403–409 (2005).
   PubMed Web of Science ®Google Scholar
• Schumann C, Lenz G, Berghofer A, Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res.89(3), 247–257 (1999).
   PubMed Web of Science ®Google Scholar
• Connelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch. Gen. Psychiatry39(5), 585–588 (1982).
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry155(5), 646–652 (1998).
   PubMed Web of Science ®Google Scholar
• Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J. Consult. Clin. Psychol.52(5), 873–878 (1984).
   PubMed Web of Science ®Google Scholar
• Fletcher RH. Patient compliance with therapeutic advice: a modern view. Mount Sinai J. Med.56, 453–458 (1989).
   PubMedGoogle Scholar
• Edelman R, Eitel P, Wadhwa NK et al. Accuracy or bias in nurses ratings of patient compliance: a comparison of treatment modality. Peritoneal Dialysis Int.16, 321–325 (1996).
   PubMed Web of Science ®Google Scholar
• Norell SE. Accuracy of patients interviews and estimates by clinical staff determining medication compliance. Social Sci. Med.15, 57–61 (1981).
   Web of Science ®Google Scholar
• Buckley PF, Correll CU. Strategies for dosing and switching antipsychotics for optimal clinical management. J. Clin. Psychiatry69(Suppl. 1), 4–17 (2008).
   Web of Science ®Google Scholar
• Gianfrancesco FD, Sajatovic M, Tafesse E, Wang RH. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. Ann. Clin. Psychiatry21(1), 3–16 (2009).
   PubMed Web of Science ®Google Scholar
• Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder. Int. Clin. Psychopharmacol.23(6), 305–316 (2008).
   PubMed Web of Science ®Google Scholar
• Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin. Ther.30(7), 1358–1374 (2008).
   PubMed Web of Science ®Google Scholar
• Miasso AI, Cassiani SH, Pedrao LJ. Bipolar affective disorder and medication therapy: identifying barriers. Rev. Lat. Am. Enfermagem16(4), 739–745 (2008).
   PubMed Web of Science ®Google Scholar
• Hassan M, Lage MJ. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. Am. J. Health Syst. Pharm.66(4), 358–365 (2009).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Biswas K, Kilbourne AK et al. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr. Serv.59(7), 753–759 (2008).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Blow FC, Kales HC et al. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int. J. Geriatr. Psychiatry22(10), 992–998 (2007).
   PubMed Web of Science ®Google Scholar
• Hassan M, Madhavan SS, Kalsekar ID et al. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Ann. Pharmacother.41(11), 1812–1818 (2007).
   PubMed Web of Science ®Google Scholar
• Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. J. Clin. Psychiatry67(2), 222–232 (2006).
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R, Angst F. Long-term outcome and mortality of treated vs. untreated bipolar and depressed patients: a preliminary report. Int J. Psychiatr. Clin. Pract.2, 115–119 (1998).
   PubMedGoogle Scholar
• Clark DC, Goebel-Fabbri AE. Lifetime risk of suicide in major affective disorders. In: Harvard Medical School Guide to Assessment and Intervention in Suicide. Jacobs D (Ed.). Jossey Bass, CA, USA 270–286 (1998).
   Google Scholar
• Baldessarini RJ, Jamison KR. Effects of medical interventions on suicidal behavior: summary and conclusions. J. Clin. Psychiatry60(Suppl. 2), 117–122 (1999).
   PubMed Web of Science ®Google Scholar
• Brodersen A, Licht RW, Vestergaard P, Olesen AV, Mortensen PB. Sixteen year mortality in patients with affective disorder commenced on lithium. Br. J. Psychiatry176, 419–433 (2000).
   Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J. Clin. Psychiatry61(Suppl. 9), 97–104 (2000).
   PubMed Web of Science ®Google Scholar
• Guze SB, Robins E. Suicide and primary affective disorders. Br. J. Psychiatry117, 437–438 (1970).
   PubMed Web of Science ®Google Scholar
• Roy A. Suicide. In: Comprehensive Textbook of Psychiatry. Kaplan HI, Sadock BJ (Eds). Williams & Wilkins, MD, USA 1414–1427 (1989).
   Google Scholar
• Angst J, Stassen HH, Gross G, Huber G, Stone MH. Suicide in affective and schizoaffective disorders. In: Affective and Schizoaffective Disorders. Marneros A, Tsuang MT (Eds). Springer-Verlag, Berlin, Germany 168–185 (1990).
   Google Scholar
• Angst J, Angst F, Stassen HS. Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry60(Suppl. 2), 57–62 (1999).
   PubMed Web of Science ®Google Scholar
• Diekstra RFW. The epidemiology of suicide and parasuicide. Acta Psychiatr. Scand.87(Suppl. 371), 9–20 (1993).
   Web of Science ®Google Scholar
• Inskip HM, Harris EC, Barraclough BB. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br. J. Psychiatry172, 35–37 (1998).
   PubMed Web of Science ®Google Scholar
• Keller MB, Lavori PW, Klerman GL et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch. Gen. Psychiatry3, 458–466 (1986).
   Google Scholar
• Mccombs JS, Nichol MB, Stimmel GL et al. Cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J. Clin. Psychiatry51(Suppl. 6), 60–69 (1990).
   PubMedGoogle Scholar
• Isacsson G, Boëthius G, Bergman U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr. Scand.85, 444–448 (1992).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Suppes T, Faedda GL, Tohen M. Pharmacological treatment of bipolar disorder throughout the life-cycle. In: Bipolar Disorder Through the Life-Cycle. Shulman KI, Tohen M, Kutcher S (Eds). John Wiley & Sons, NY, USA 299–338 (1996).
   Google Scholar
• Suominen KH, Isometsa E, Hendriksson MM, Ostamo AI, Lonnqvist JK. Inadequate treatment for major depression both before and after attempted suicide. Am. J. Psychiatry155, 1778–1780 (1998).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J. Clin. Psychiatry60(Suppl. 2), 77–84 (1999).
   PubMed Web of Science ®Google Scholar
• Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf.3, 186–212 (1993).
   Google Scholar
• Perry PJ. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic vs. selective serotonin reuptake inhibitor antidepressants. J. Affect. Disord.39, 1–6 (1996).
   PubMed Web of Science ®Google Scholar
• Muller-Oerlinghausen B, Berghöfer A. Antidepressants and suicidal risk. J. Clin. Psychiatry60(Suppl. 2), 94–99 (1999).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Ioanitescu D, Ragade J et al. Suicide risk and antidepressant treatment: a meta-analysis. Acta Psychiatr. Scand.104, 163–172 (2001).
   PubMed Web of Science ®Google Scholar
• Freemantle N, House A, Song F, Mason JM, Sheldon TA. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ309, 249–253 (1994).
   PubMed Web of Science ®Google Scholar
• Ohberg A, Lonqvist J, Sarna S, Vuori E, Penttila A. Trends and availability of suicide methods in Finland: proposals for restrictive measures. Br. J. Psychiatry166, 35–43 (1995).
   PubMed Web of Science ®Google Scholar
• Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J. Clin. Psychopharmacol.13, 397–408 (1993).
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am. J. Psychiatry155(5), 638–645 (1998).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Davis P et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord.8(5 Pt 2), 625–639 (2006).
   PubMed Web of Science ®Google Scholar
• Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J. Clin. Psychiatry68(3), 380–383 (2007).
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Hennen J et al. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J. Clin. Psychiatry59(8), 405–414 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am. J. Psychiatry153(8), 993–1000 (1996).
   PubMed Web of Science ®Google Scholar
• Strober M, Morrell W, Lampert C, Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am. J. Psychiatry147(4), 457–461 (1990).
   PubMed Web of Science ®Google Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv. Rev. Psychiatry1(3), 131–144 (1993).
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J. Clin. Psychiatry61(Suppl. 9), 97–104 (2000).
   PubMed Web of Science ®Google Scholar
• Gonzales-Pinto A, Mosuera F, Alonso M et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord.8, 618–621 (2006).
   PubMed Web of Science ®Google Scholar
• Dalton EJ, Cate-Carter TD, Mundo E et al. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord.5, 58–61 (2003).
   PubMed Web of Science ®Google Scholar
• Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J. Affect. Disord.37, 43–49 (1996).
   PubMed Web of Science ®Google Scholar
• Goldberg JF. Optimizing treatment outcomes in bipolar disorder under ordinary conditions. J. Clin. Psychiatry69(Suppl. 3), 11–19 (2008).
   PubMed Web of Science ®Google Scholar
• Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr. Scand.104(3), 163–172 (2001).
   PubMed Web of Science ®Google Scholar
• Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior part 3: impact of antipsychotics. J. Affect. Disord.103(1–3), 23–28 (2007).
   PubMed Web of Science ®Google Scholar
• Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy and suicidal behavior part 2. The impact of antidepressants. J. Affect. Disord.103(1–3), 13–21 (2007).
   PubMed Web of Science ®Google Scholar
• Pampallona S, Bollini P, Tibaldi G et al. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch. Gen. Psychiatry61, 714–719 (2004).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr. Serv.55(3), 264–269 (2004).
   PubMed Web of Science ®Google Scholar
• Clarkin JF, Carpenter D, Hull J, Wilner P, Glick I. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatr. Serv.49, 531–533 (1998).
   PubMed Web of Science ®Google Scholar
• Anderson C, Griffin S, Rossi A et al. A comparative study of the impact of education vs process groups for families of patients with affective disorders. Fam. Process25, 185–205 (1986).
   PubMed Web of Science ®Google Scholar
• van Gent EM, Zwart FM. Psychoeducation of partners of bipolar-manic patients. J. Affect. Disord.21(1), 15–18 (1991).
   PubMed Web of Science ®Google Scholar
• Bauer MS, Wisniewski SR, Marangell LB et al. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J. Clin. Psychiatry67, 48–55 (2006).
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ, George EL, Richards JA et al. A randomised study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch. Gen. Psychiatry60, 904–912 (2003).
   PubMed Web of Science ®Google Scholar
• Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord.6, 504–518 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressant medication compliance. Can. J. Psychiatry49(2), 106–113 (2004).
   PubMed Web of Science ®Google Scholar
• Higgins N, Livingston G, Katona C. Concordance therapy: an intervention to help older people take antidepressants. J. Affect. Disord.81(3), 287–291 (2004).
   PubMed Web of Science ®Google Scholar
• Kemp R, Hayward P, Applewhaite G et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ312, 345–349 (1996).
   PubMed Web of Science ®Google Scholar
• Scott J, Tacchi MJ. A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. Bipolar Disord.4, 386–392 (2002).
   PubMed Web of Science ®Google Scholar
• Altamura AC, Mauri M. Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants. Br. J. Clin. Pharmacol.20(6), 714–716 (1985).
   PubMed Web of Science ®Google Scholar
• Robinson P, Katon W, Von Korff M et al. The education of depressed primary care patients: what do patients think of interactive booklets and a video? J. Fam. Pract.44(6), 562–571 (1997).
   PubMed Web of Science ®Google Scholar
• Haynes R, Mckibbon K, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet348, 383–396 (1996).
   PubMed Web of Science ®Google Scholar
• Kutcher S, Leblanc J, Maclaren C, Hadrava V. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog. Neuropsychopharmacol. Biol. Psychiatry26, 591–596 (2002).
   PubMed Web of Science ®Google Scholar
• Hoffman L, Enders J, Luo J et al. Impact of an antidepressant management program on medication adherence. Am. J. Manag. Care9(1), 70–80 (2003).
   PubMed Web of Science ®Google Scholar
• Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med. Care42(12), 1176–1185 (2004).
   PubMed Web of Science ®Google Scholar
• Depp CA, Moore DJ, Patterson TL, Lebowitz BD, Jeste DV. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin. Neurosci.10(2), 239–250 (2008).
   PubMedGoogle Scholar
• Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. J. Clin. Psychiatry66(Suppl. 1), 24–29 (2005).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Pinto A, Gonzalez C, Enjuto S et al. Psychoeducation and cognitive–behavioral therapy in bipolar disorder: an update. Acta Psychiatr. Scand.109, 83–90 (2004).
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Martinez-Aran A et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch. Gen. Psychiatry60(4), 402–407 (2003).
   PubMed Web of Science ®Google Scholar
• Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J. Clin. Psychiatry64(12), 1415–1420 (2003).
   PubMed Web of Science ®Google Scholar
• Roter D, Hall J, Merisca R et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med. Care36, 1138–1161 (1998).
   PubMed Web of Science ®Google Scholar
• Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medication. Cochrane Database Syst. Rev.2, CD000011 (2002).
   Google Scholar
• Colom F, Lam D. Psychoeducation: improving outcomes in bipolar disorder. Eur. Psychiatry20, 359–364 (2005).
   PubMed Web of Science ®Google Scholar
• Reinares M, Colom F, Martinez-Aran A, Benabarre A, Vieta E. Therapeutic interventions focused on the family of bipolar patients. Psychother. Psychosom.71(1), 2–10 (2002).
   PubMed Web of Science ®Google Scholar
• Scott J, Wright J. Cognitive therapy for severe mental disorders. In: Review of Psychiatry. APA Press, Washington, DC, USA 135–170 (1997).
   Google Scholar
• Goodwin FK, Jamison KR. Manic-Depressive Illness. Oxford University Press, NY, USA (2007).
   Google Scholar
• Frank E, Kupfer DJ, Perel JM et al. Three year outcomes in maintenance therapies in recurrent depression. Arch. Gen. Psychiatry47, 1093–1099 (1990).
   PubMed Web of Science ®Google Scholar
• Myers ED, Calvert EJ. Information, compliance and side effects: a study of patients on antidepressant medication. Br. J. Clin. Pharmacol.17, 21–25 (1984).
   PubMed Web of Science ®Google Scholar
• Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Can. J. Psychiatry25(8), 638–645 (1980).
   PubMed Web of Science ®Google Scholar
• Essex B, Roig R, Renshaw J. Pilot study of records of shared care for people with mental illnesses. BMJ300, 1442–1446 (1990).
   PubMed Web of Science ®Google Scholar
• Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness – the chronic care model. Part 2. JAMA288, 1909–1914 (2002).
   PubMed Web of Science ®Google Scholar
• Coulter A, Elwyn G. What do patients want from high quality general practice and how do we involve them in improvement? Br. J. Gen. Pract.52, S22–S26 (2002).
   PubMed Web of Science ®Google Scholar
• van Os T, Ormel J, van den Brink R et al. Training primary care physicians improve the management of depression. Gen. Hosp. Psychiatry21, 168–176 (1999).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Goldberg D. Improving outcomes in depression – the whole process of care needs to be enhanced. BMJ323, 948–949 (2001).
   PubMed Web of Science ®Google Scholar
• Fuertes JN, Boylan LS, Fontanella JA. Behavioral indices in medical care outcome: the working alliance, adherence, and related factors. J. Gen. Intern. Med.24, 80–85 (2008).
   PubMed Web of Science ®Google Scholar
• Lam DH, Watkins ER, Hayward P et al. A randomized controlled study of cognitive therapy of relapse prevention for bipolar affective disorder: outcome of the first year. Arch. Gen. Psychiatry60, 145–152 (2003).
   PubMed Web of Science ®Google Scholar
• Lam DH, Bright J, Jones S et al. Cognitive therapy for bipolar illness: a pilot study of relapse prevention. Cognit. Ther. Res.24, 503–520 (2000).
   Web of Science ®Google Scholar
• Schmitz JM, Oswald LM, Jacks SD et al. Relapse prevention treatment for cocaine dependence: group vs. individual format. Addict. Behav.22(3), 405–418 (1997).
   PubMed Web of Science ®Google Scholar
• Scott J, Paykel E, Morriss R et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br. J. Psychiatry188, 313–320 (2006).
   PubMed Web of Science ®Google Scholar
• Ball JR, Mitchell PB, Corry JC et al. A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. J. Clin. Psychiatry67(2), 277–286 (2006).
   PubMed Web of Science ®Google Scholar
• Papageorgiou A, King M, Janmohamed A, Davidson O, Dawson J. Advance directives for patients compulsorily admitted to hospital with serious mental illness. Randomised controlled trial. Br. J. Psychiatry181, 513–519 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs.22(1), 36–44 (2005).
   PubMed Web of Science ®Google Scholar
• Simoneau TL, Miklowitz DJ, Richards JA, Saleem R, George EL. Bipolar disorder and family communication: effects of a psychoeducational treatment program. J. Abnorm. Psychol.108, 588–597 (1999).
   PubMed Web of Science ®Google Scholar
• Scott J. Psychotherapy for bipolar disorder. Br. J. Psychiatry167, 581–588 (1995).
   PubMed Web of Science ®Google Scholar
• Myers ED, Branthwaite A. Out-patient compliance with antidepressant medication. Br. J. Psychiatry160, 83–86 (1992).
   PubMed Web of Science ®Google Scholar
• Van Putten T. Why do patients with manic-depressive illness stop their lithium? Compr. Psychiatry16, 179–183 (1975).
   PubMed Web of Science ®Google Scholar
• Blackwell B. Treatment adherence. Br. J. Psychiatry129, 513–531 (1976).
   PubMed Web of Science ®Google Scholar
• Salzman C. Medication compliance in the elderly. J. Clin. Psychiatry56(Suppl. 1), 18–22 (1995).
   PubMed Web of Science ®Google Scholar
• Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr. Scand.101, 119–124 (2000).
   PubMed Web of Science ®Google Scholar
• Howard K, Rickels K, Mock JE et al. Therapeutic style and attrition rates from psychiatric drug treatment. J. Nerv. Ment. Dis.150, 102–110 (1970).
   PubMedGoogle Scholar
• Milburn HJ, Cochran GM. Letter: treating the patient as a decision maker is not always appropriate. BMJ314, 1906 (1997).
   PubMedGoogle Scholar
• Mullen PD. Compliance becomes concordance. BMJ314, 691–692 (1997).
   PubMed Web of Science ®Google Scholar
• Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiatr. Scand.100, 167–175 (2000).
   Web of Science ®Google Scholar
• Fenton WS, Blyler CB, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull.23, 637–651 (1997).
   PubMed Web of Science ®Google Scholar
• Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am. J. Psychiatry159, 909–916 (2002).
   PubMed Web of Science ®Google Scholar
• Rihmer Z, Barsi J, Veg K, Katona CL. Suicide rates in Hungary correlate negatively with reported rates of depression. J. Affect. Disord.20, 87–91 (1990).
   PubMed Web of Science ®Google Scholar
• Rihmer Z, Rutz W, Barsi J. Suicide rate, prevalence of diagnosed depression and prevalence of working physicians in Hungary. Acta Psychiatr. Scand.88, 391–394 (1993).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L. Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview. Clin. Drug Investig.15(4), 337–351 (1998).
   PubMed Web of Science ®Google Scholar
• Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J. Affect. Disord.18(4), 259–266 (1990).
   PubMed Web of Science ®Google Scholar
• Regier DA, Narrow WE, Rae DS et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry50(2), 85–94 (1993).
   PubMed Web of Science ®Google Scholar
• Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry170, 205–228 (1997).
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Martinez-Aran A et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J. Clin. Psychiatry61(8), 549–555 (2000).
   PubMedGoogle Scholar
• Pompili M, Rihmer Z, Innamorati M et al. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev. Neurother.9(1), 109–136 (2009).
   PubMed Web of Science ®Google Scholar
• Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA269, 2779–2781 (1993).
   PubMed Web of Science ®Google Scholar
• Harvey N, Summerton A, Forrest A, Peet M. Compliance, the LAQ and a new laboratory method of measuring RBC lithium. J. Clin. Psychiatry51, 126–127 (1990).
   PubMed Web of Science ®Google Scholar
• Gengo F, Frazer A, Ramsey TA, Mendels J. The lithium ratio as a guide to patient compliance. Compr. Psychiatry21(4), 276–280 (1980).
   PubMed Web of Science ®Google Scholar
• Harvey NS, Peet M. Lithium maintenance: 2. Effects of personality and attitude on health information acquisition and compliance. Br. J. Psychiatry158, 200–204 (1991).
   PubMed Web of Science ®Google Scholar
• Kelly GR, Mamon JA, Scott JE. Utility of the health belief model in examining medication compliance among psychiatric outpatients. Soc. Sci. Med.25(11), 1205–1211 (1987).
   PubMed Web of Science ®Google Scholar
• van Geffen EC, Gardarsdottir H, van Hulten R et al. Initiation of antidepressant therapy: do patients follow the GP’s prescription? Br. J. Gen. Pract.59(559), 81–87 (2009).
   PubMed Web of Science ®Google Scholar
• ten Doesschate MC, Bockting CL, Koeter MW, Schene AH. Predictors of nonadherence to continuation and maintenance antidepressant medication in patients with remitted recurrent depression. J. Clin. Psychiatry70(1), 63–69 (2009).
   PubMed Web of Science ®Google Scholar
• Yen CF, Lee Y, Tang TC et al. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders. J. Nerv. Ment. Dis.197(3), 172–177 (2009).
   PubMed Web of Science ®Google Scholar